China Medical GatewayLoading your healthcare gateway…

Sichuan Cancer Hospital

Sichuan Cancer Hospital — Chengdu

Hospital Profile

Sichuan Cancer Hospital (Sichuan Cancer Prevention and Treatment Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China) was established in 1979. It is a Grade III, Class A specialized hospital for cancer. The Sichuan Province Tumor and Radiotherapy Quality Control Center is also located in this hospital. It has been selected as a national key clinical specialty in oncology, a unit for the national project to enhance the diagnosis and treatment capabilities of difficult and complicated diseases, and one of the first national demonstration hospitals for standardized cancer pain treatment. The hospital is at the domestic or Southwest leading level in the comprehensive treatment of lung cancer, esophageal cancer, breast cancer, colorectal cancer, liver cancer, lymphoma, and head and neck/gynecological tumors, as well as in standardized oncologic surgery and micro-invasive surgery. It has successively received honors such as the Advanced Collective in the National Health System and National Civilized Unit.

Medical Milestones

The hospital was officially established in February 1979; in 2011, it was awarded the title of 'First Batch of Excellent Nursing Demonstration Wards' by the former Ministry of Health and obtained national GCP certification; in July 2016, it signed an agreement with the University of Electronic Science and Technology to jointly establish a medical school, becoming its affiliated cancer hospital; in 2017, the medical school was approved to enroll undergraduates in clinical medicine and nursing; on November 23, 2017, the first phase of the Tianfu Campus (Sichuan Provincial Cancer Diagnosis and Treatment Center) project commenced construction.

Key Capabilities & Patient Care

There are 33 clinical departments (wards), 14 medical and technical departments, 6 clinical translational research divisions, and 1 basic oncology research division. The hospital has 13 key medical disciplines recognized by Sichuan Province, with oncology nursing being the only Grade-A key discipline in the province (offering specialized clinics for intravenous access, psychological counseling, and wound and ostomy management). The hospital actively fulfills its public welfare responsibilities, relying on the Sichuan Cancer Prevention and Control Center and the Provincial Anti-Cancer Association to carry out cancer screening and early diagnosis and treatment across 13 project sites in the province, screening more than 190,000 people, with an early diagnosis rate of 77.33%.

Advanced Technology

Possesses the largest close-range radiotherapy center in the western region, equipped with 9 advanced linear accelerator systems including TomoTherapy, Novalis TX, and Infinity, leading nationally and internationally in IMRT, SBRT, 4D-IGRT, modern precision radiotherapy, and brachytherapy. There is a modern tumor research institute covering over 2,600 square meters and a provincial-level tumor molecular targeted gene research laboratory. It serves as a graduate training and standardized training base for six universities, including the University of Electronic Science and Technology of China. Statistics: • Bed capacity: 1,500 licensed beds, 1,590 actual open beds (Tianfu campus under construction) • Total staff: 2,313 (2025) • Inpatient cases: 81,000 (2023) • Outpatient and emergency visits: 760,000 annually (2023) • Inpatient and elective surgeries: 21,000 annually (2023) • Number of senior physicians: 417 (2025)

International Patient Services

Carry out extensive international exchange and cooperation, establish friendly partnerships with Italy's Maggiore Charity University Hospital, Russia's St. Petersburg Cancer Center, the Huntsman Cancer Hospital at the University of Utah in the United States, Duke University School of Medicine, etc., serving as the first remote pathology partner of Duke University School of Medicine in China; received important foreign guests including multiple Nobel Prize winners, sent over a hundred people abroad for exchanges, and over 70 people to the U.S., Germany, Japan, and Canada for long-term study. (No specific services of the independent special needs/international department were mentioned)

Return to Home